Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is caused by mutations in the gene that encodes for the protein dystrophin, which is critical for muscle function. There is currently no cure for DMD, apart from treatments with physical therapy, and assistive devices, corticosteroid drugs can help manage symptoms and improve quality of life. Protheragen offers a full range of anti-duchenne muscular dystrophy APIs to support customer research worldwide.